Bristol-Myers Squibb Company
Ownership
Ownership Structure
Who owns Bristol-Myers Squibb Company (BMY)? This page shows the largest institutions and funds, the ownership structure and the latest insider transactions. 99.8% of the shares are freely tradable; institutional investors hold 83.8%.
Largest Shareholders
Institutions
| Name | Stake (%) | Shares | Change (%) | Date |
|---|---|---|---|---|
| BlackRock Inc | 8.83 | 180,384,994 | +5.1 | 06/30/2026 |
| Vanguard Capital Management, LLC | 6.53 | 133,337,856 | +0.8 | 06/30/2026 |
| State Street Corp | 5.01 | 102,408,940 | +3.9 | 06/30/2026 |
| JPMorgan Chase & Co | 3.51 | 71,713,442 | -22.5 | 06/30/2026 |
| Charles Schwab Investment Management Inc | 3.31 | 67,595,177 | +10.6 | 06/30/2026 |
| Geode Capital Management, LLC | 2.76 | 56,443,077 | +2.1 | 06/30/2026 |
| Vanguard Portfolio Management, LLC | 2.29 | 46,873,015 | +1.4 | 06/30/2026 |
Funds
| Name | Stake (%) | Shares | Change (%) | Date |
|---|---|---|---|---|
| Vanguard MStar Total Stk Mkt Idx Invest | 3.17 | 64,845,301 | -0.1 | 09/30/2026 |
| Schwab US Dividend Equity ETF™ | 2.78 | 56,808,037 | +0.3 | 09/30/2026 |
| Vanguard 500 Index Investor | 2.63 | 53,647,691 | -1.1 | 09/30/2026 |
Largest reported positions according to regulatory filings; stake as a percentage of shares outstanding, change versus the previous filing. Source: fundamentals data.
Insider holdings
| Person | Role | Shares | Value | As of | Type |
|---|---|---|---|---|---|
| Massacesi Cristian | EVP,Chief Med Offr,Head of Dev | 18,748 | 1,171,750 $ | Sep 9, 2026 | direct |
| Holzer Phil M | SVP and Controller | 16,862 | 1,053,875 $ | Aug 25, 2026 | direct |
| Gallman Cari | EVP, General Counsel | 15,876 | 992,250 $ | Oct 2, 2026 | direct |
| Short Bartie Wendy | EVP, Corporate Affairs | 12,684 | 792,750 $ | Sep 1, 2026 | direct |
Holdings as of each person's most recent SEC Form 4 filing — excluding options and RSUs, which are not shares yet. Holdings may have changed between two filings.
Insiders
Insider Transactions
| Date | Person | Role | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Oct 2, 2026 | Gallman Cari | EVP, General Counsel | Other | 2,332 | 61.15 | 142,602 |
| Oct 2, 2026 | Gallman Cari | EVP, General Counsel | Other | 4,559 | 0.00 | – |
| Sep 9, 2026 | Massacesi Cristian | EVP,Chief Med Offr,Head of Dev | Sell | 6,249 | 64.57 | 403,498 |
| Sep 1, 2026 | Short Bartie Wendy | EVP, Corporate Affairs | Other | 633 | 66.92 | 42,360 |
| Sep 1, 2026 | Short Bartie Wendy | EVP, Corporate Affairs | Other | 1,236 | 66.92 | 82,713 |
| Aug 25, 2026 | Holzer Phil M | SVP and Controller | Sell | 500 | 67.50 | 33,750 |
| Aug 1, 2026 | Massacesi Cristian | EVP,Chief Med Offr,Head of Dev | Other | 26,175 | 65.31 | 1,709,489 |
| Aug 1, 2026 | Massacesi Cristian | EVP,Chief Med Offr,Head of Dev | Other | 51,172 | 0.00 | – |
| Aug 1, 2026 | Gallman Cari | EVP, General Counsel | Other | 543 | 65.31 | 35,463 |
| Aug 1, 2026 | Gallman Cari | EVP, General Counsel | Other | 1,061 | 0.00 | – |
Reportable transactions by officers and major shareholders from SEC Form 4 filings. "Other" includes things like stock grants and option exercises without a buy/sell character. View all insider transactions →
Data as of: October 30, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.